All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 43.45
(10.0%)
TWD 43.45
(10.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 859.54 Million TWD | -31.14% |
| 2022 | 1.24 Billion TWD | 111.1% |
| 2021 | 591.27 Million TWD | 135.39% |
| 2020 | 251.19 Million TWD | 17.6% |
| 2019 | 213.59 Million TWD | -51.32% |
| 2018 | 438.8 Million TWD | 28.24% |
| 2017 | 342.18 Million TWD | -38.41% |
| 2016 | 555.55 Million TWD | -39.88% |
| 2015 | 924.09 Million TWD | -3.5% |
| 2014 | 957.63 Million TWD | 20.87% |
| 2013 | 792.3 Million TWD | 21.99% |
| 2012 | 649.48 Million TWD | 57.92% |
| 2011 | 411.26 Million TWD | 48.53% |
| 2010 | 276.88 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 879.46 Million TWD | 2.32% |
| 2024 Q2 | 895.37 Million TWD | 1.81% |
| 2023 Q4 | 859.54 Million TWD | -14.85% |
| 2023 Q3 | 1 Billion TWD | 5.1% |
| 2023 Q2 | 960.41 Million TWD | -23.99% |
| 2023 Q1 | 1.26 Billion TWD | 1.23% |
| 2023 FY | 859.54 Million TWD | -31.14% |
| 2022 FY | 1.24 Billion TWD | 111.1% |
| 2022 Q4 | 1.24 Billion TWD | -28.86% |
| 2022 Q3 | 1.75 Billion TWD | 86.09% |
| 2022 Q2 | 942.84 Million TWD | 42.37% |
| 2022 Q1 | 662.26 Million TWD | 12.01% |
| 2021 FY | 591.27 Million TWD | 135.39% |
| 2021 Q1 | 446.34 Million TWD | 77.69% |
| 2021 Q2 | 348.5 Million TWD | -21.92% |
| 2021 Q3 | 468.18 Million TWD | 34.34% |
| 2021 Q4 | 591.27 Million TWD | 26.29% |
| 2020 FY | 251.19 Million TWD | 17.6% |
| 2020 Q2 | 428.67 Million TWD | 27.99% |
| 2020 Q3 | 200.43 Million TWD | -53.24% |
| 2020 Q4 | 251.19 Million TWD | 25.32% |
| 2020 Q1 | 334.92 Million TWD | 56.8% |
| 2019 Q1 | 525.74 Million TWD | 19.81% |
| 2019 Q3 | 163.71 Million TWD | -70.01% |
| 2019 FY | 213.59 Million TWD | -51.32% |
| 2019 Q2 | 545.99 Million TWD | 3.85% |
| 2019 Q4 | 213.59 Million TWD | 30.47% |
| 2018 Q2 | 1 Billion TWD | 58.89% |
| 2018 FY | 438.8 Million TWD | 28.24% |
| 2018 Q4 | 438.8 Million TWD | -26.99% |
| 2018 Q3 | 600.99 Million TWD | -40.37% |
| 2018 Q1 | 634.29 Million TWD | 85.37% |
| 2017 FY | 342.18 Million TWD | -38.41% |
| 2017 Q1 | 448 Million TWD | -19.36% |
| 2017 Q2 | 673.54 Million TWD | 50.34% |
| 2017 Q3 | 517.45 Million TWD | -23.17% |
| 2017 Q4 | 342.18 Million TWD | -33.87% |
| 2016 FY | 555.55 Million TWD | -39.88% |
| 2016 Q4 | 555.55 Million TWD | -29.97% |
| 2016 Q3 | 793.24 Million TWD | -25.47% |
| 2016 Q2 | 1.06 Billion TWD | 13.41% |
| 2016 Q1 | 938.51 Million TWD | 1.56% |
| 2015 FY | 924.09 Million TWD | -3.5% |
| 2015 Q4 | 924.09 Million TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2014 FY | 957.63 Million TWD | 20.87% |
| 2013 Q1 | 775.58 Million TWD | 19.42% |
| 2013 FY | 792.3 Million TWD | 21.99% |
| 2012 FY | 649.48 Million TWD | 57.92% |
| 2012 Q4 | 649.48 Million TWD | 0.0% |
| 2011 FY | 411.26 Million TWD | 48.53% |
| 2010 FY | 276.88 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Sinon Corporation | 6.79 Billion TWD | 87.355% |
| Taiwan Fertilizer Co., Ltd. | 26.78 Billion TWD | 96.791% |
| CH Biotech R&D Co., Ltd. | 1.12 Billion TWD | 23.871% |